Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cephalon acquires Anesta; Anesta's Actiq receives U.K. approval

Oct. 13, 2000

Shire submits NDA for once-daily Adderall for ADHD

Oct. 13, 2000

Potentially safe and effective treatments for multiple sclerosis discovered at Active Biotech

Oct. 11, 2000

Novel serotonergic agents from Sankyo and their use in CNS disorders

Oct. 11, 2000

Roche discloses new NK1 antagonists and their therapeutic applications

Oct. 11, 2000

New therapeutic approach to AD licensed by Neurogenetics

Oct. 11, 2000

Roche's new NK1 receptor antagonists intended particularly for depression and emesis

Oct. 10, 2000

Sulfonamides designed by two major labs as potential Alzheimer's disease therapies

Oct. 10, 2000

NOS inhibitors in the Pfizer pipeline reported in patent literature

Oct. 10, 2000

Benzenesulfonamide B2 antagonists synthesized at Fournier

Oct. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...